Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol

• Shinobu Shimizu ,

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Writing – original draft, Writing – review & editing

  * E-mail: marus@med.nagoya-u.ac.jp (SM); shimizu.shinobu.w3@f.mail.nagoya-u.ac.jp (SS)

  Affiliation Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan

  https://orcid.org/0000-0001-9066-3489

  ⨯
• Akihito Tanaka,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Writing – review & editing

  Affiliation Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan

  https://orcid.org/0000-0001-8866-5901

  ⨯
• Nao Matsuyama,

  Roles Conceptualization, Methodology, Writing – review & editing

  Current address: Ascent Development Services, Inc., Shibuya-ku, Tokyo, Japan

  Affiliation Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan

  ⨯
• Fumie Kinoshita,

  Roles Conceptualization, Formal analysis, Methodology, Validation, Writing – review & editing

  Affiliation Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan

  ⨯
• Kazuhiro Furuhashi,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan

  ⨯
• Shoichi Maruyama ,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing – review & editing

  * E-mail: marus@med.nagoya-u.ac.jp (SM); shimizu.shinobu.w3@f.mail.nagoya-u.ac.jp (SS)

  Affiliation Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

  https://orcid.org/0000-0002-8858-632X

  ⨯
• the PRIME Study Group

  ¶Membership of the PRIME study group is provided in the Acknowledgements.

  ⨯